[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355334-105":59,"doc-detail-355334-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identifying-plasma-proteins-associated-with-risk-of-solid-cancers-a-25-year-prospective-analysis","Identifying Plasma Proteins Associated with Risk of Solid Cancers - A 25-Year Prospective Analysis","","Investigated pre-diagnostic proteomic risk markers for seven solid cancers in a multi-center prospective cohort, focusing on signals independent of established risk factors. Used SomaScan 5K to quantify 4,712 unique plasma proteins (4,955 aptamers) in ARIC participants (n=9,391). Over up to 25.9 years, analyzed incident cases across cancer sites, applying FDR correction and identifying protein–cancer associations, including novel liver and lung proteins. External validation in EPIC confirmed consistent directions and nominal significance; time-lagged results indicated most markers reflect long-term risk more than five years pre-diagnosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identifying-plasma-proteins-associated-with-risk-of-solid-cancers-a-25-year-prospective-analysis/355334/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identifying-plasma-proteins-associated-with-risk-of-solid-cancers-a-25-year-prospective-analysis/355334.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of this study?","Question",{"text":112,"@type":113},"To identify pre-diagnostic plasma proteomic markers associated with the risk of seven solid cancers, independent of known risk factors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were plasma proteins measured?",{"text":117,"@type":113},"Plasma proteomics were assessed using the SomaScan 5K assay, profiling 4,712 unique plasma proteins (4,955 aptamers) in the ARIC cohort.",{"name":119,"@type":110,"acceptedAnswer":120},"Were the findings validated externally?",{"text":121,"@type":113},"Yes. Results were validated in the EPIC cohort using a SomaScan 7K assay, where most FDR-significant proteins showed consistent effect directions and nominal significance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355334,1790639309,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","medRxiv preprint doi: [https://doi.org/10.64898/2026.03.16.26348527](https://doi.org/10.64898/2026.03.16.26348527); this version posted March 18, 2026. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-NC-ND 4.0 International license .  \nIdentifying Plasma Proteins Associated with Risk of Solid Cancers: A 25-Year Prospective Analysis of 4,712 Circulating  \nProteins in the ARIC Study  \nZiqiao Wang 1,2 , Vernon A. Burk3 , Zhe Huang4 , Hana Zahed5 , David C. Muller6 , James Yarmolinsky6 , Matthew A. Lee5 , Corinne E. Joshu3 , Zhike (Coco) Lin3 , Anna Prizment7 , Kenneth R. Butler8 , David J. Couper9 , Karl Smith-Byrne4 , P. Martijn Kolijn 10,11,12 , Roel  \nC. H. Vermeulen 10,11 , Elio Riboli6 , Marc J. Gunter5,6 , Josef Coresh 13,14 , Nilanjan Chatterjee 15,16,*,\\# , Elizabeth A. Platz3,16,*,\\#  \n1. Department of Genome Sciences, University of Virginia, Charlottesville, Virginia, United States of America  \n2. UVA Comprehensive Cancer Center, Charlottesville, Virginia, United States of America  \n3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America  \n4. Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom  \n5. International Agency for Research on Cancer, Lyon, France  \n6. Cancer Epidemiology and Prevention Research Unit, School of Public Health, Imperial College London, London, United Kingdom  \n7. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA  \n8. University of Mississippi Medical Center, Jackson, Mississippi  \n9. Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States  \n10. Division of Environmental Epidemiology and Veterinary Public Health, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands  \n11. Julius Global Health, the Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands  \n12. Department of Immunology, Erasmus MC, Rotterdam, the Netherlands  \n13. Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States  \nNOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.  \nmedRxiv preprint doi: [https://doi.org/10.64898/2026.03.16.26348527](https://doi.org/10.64898/2026.03.16.26348527); this version posted March 18, 2026. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-NC-ND 4.0 International license .  \n14. Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States  \n15. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America  \n16. Department of Oncology, Johns Hopkins University School of Medicine, and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States of America  \n*Contributed equally  \n\\#Correspondence to: [nchatte2@jhu.edu](nchatte2@jhu.edu) and [eplatz1@jhu.edu](eplatz1@jhu.edu)  \nAbstract  \nThis study investigated potential pre-diagnostic proteomic risk markers for 7 solid cancers independent of known risk factors within a multi-center, prospective cohort study. Using the SomaScan® 5K assay, we analyzed 4,712 unique plasma proteins (4,955 aptamers) in the Atherosclerosis Risk in Communities (ARIC) study among 9,391 middle-aged and older Black (23%) and White (77%) men and women. Over a maximum follow-up of 25.9 years, incident cases included 136 bladder, 271 colorectal, 96 kidney, 22 liver, 416 lung, 88","cbCairiVnpkaakxT","https://ap.wps.com/l/cbCairiVnpkaakxT","pdf",1742856,47,"English","# Abstract\n## Study design and cohort\n## Proteomic assay and protein coverage\n## Cancer outcomes and statistical findings\n## External validation and time-lagged analysis","[{\"question\":\"What was the main goal of this study?\",\"answer\":\"To identify pre-diagnostic plasma proteomic markers associated with the risk of seven solid cancers, independent of known risk factors.\"},{\"question\":\"How were plasma proteins measured?\",\"answer\":\"Plasma proteomics were assessed using the SomaScan 5K assay, profiling 4,712 unique plasma proteins (4,955 aptamers) in the ARIC cohort.\"},{\"question\":\"Were the findings validated externally?\",\"answer\":\"Yes. Results were validated in the EPIC cohort using a SomaScan 7K assay, where most FDR-significant proteins showed consistent effect directions and nominal significance.\"}]","Identifying Plasma Proteins Associated with Risk of Solid Cancers - A 25-Year Prospective Analysis | PDF",1790117853,118,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/863ef6f4a12089a40a72db2f9cb8b010.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76377518aa1909318a957f271957ba32.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90483cb6dde3a0fbccdabc2fddece5e4.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28817073a2a2a2c280a5b6969379a877.webp",980,1268,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a9249b64779b622167ef32be9e25169.webp",979,1267]